SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-209168
Filing Date
2023-08-10
Accepted
2023-08-10 17:04:56
Documents
4
Effectiveness Date
2023-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 POS d511552ds8pos.htm S-8 POS 57421
2 EX-5.1 d511552dex51.htm EX-5.1 10660
3 EX-23.1 d511552dex231.htm EX-23.1 2235
4 GRAPHIC g511552g45k93.jpg GRAPHIC 8211
  Complete submission text file 0001193125-23-209168.txt   82980
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-229953 | Film No.: 231160533
SIC: 2834 Pharmaceutical Preparations